The Efficacy of Lenvatinib and Everolimus in Chromophobe-type Non-Clear-Cell Renal Cell Carcinoma: A Case Report and Literature Review

被引：3
作者：
Schwartz, Candice [1 ]
Pfanzelter, Nicklas [2 ]
Kuzel, Timothy M. [2 ]
机构：
[1] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA
[2] Rush Univ, Med Ctr, Dept Internal Med, Div Hematol Oncol Cell Therapy, Chicago, IL 60612 USA
来源：
CLINICAL GENITOURINARY CANCER | 2017年 / 15卷 / 05期
关键词：
Chromophobe; Everolimus; Lenvatinib; Noneclear-cell renal cell carcinoma; Treatment; OPEN-LABEL; SUNITINIB; MULTICENTER; PHASE-2;
D O I：
10.1016/j.clgc.2017.05.017
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
First- and second-line treatments for metastatic none clear-cell renal cell carcinoma (nccRCC) are not extensively studied and based on the well-defined treatments for metastatic clear cell renal cell carcinoma (ccRCC). Lenvatinib and everolimus have been studied in patients with ccRCC and are now established second-line therapy. This case report describes the use of lenvatinib and everolimus in a patient with metastatic nccRCC, and resultant marked reduction in tumor burden. Although it has been studied in patients with ccRCC, additional trials evaluating lenvatinib and everolimus may confirm the efficacy of this treatment regimen in patients with nccRCC.
引用
收藏
页码：E903 / E906
页数：4
相关论文
共 50 条
[21]   An overview of the clinical use of cabozantinib in the treatment of advanced non-clear-cell renal cell carcinoma (NCCRCC) [J].
D'Angelo, Alberto ;
Bagby, Stefan ;
Di Pierro, Giulia ;
Chirra, Martina ;
Nobili, Stefania ;
Mini, Enrico ;
Villari, Donata ;
Roviello, Giandomenico .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 149
[22]   Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia [J].
Naher, Sayeda ;
Padinharakam, Shamsudheen ;
Balakrishnar, Bavanthi ;
Chua, Wei ;
Descallar, Joseph ;
Adams, Diana ;
de Souza, Paul ;
Harrison, Michelle ;
Lim, Stephanie .
CLINICAL GENITOURINARY CANCER, 2019, 17 (03) :E565-E569
[23]   Activity of lenvatinib plus everolimus combination in a heavily pretreated patient with papillary renal cell carcinoma: a case report [J].
Zielli, Teresa ;
Gnetti, Letizia ;
Buti, Sebastiano .
TUMORI JOURNAL, 2020, 106 (06) :NP79-NP83
[24]   Recommendations on managing lenvatinib and everolimus in patients with advanced or metastatic renal cell carcinoma [J].
Grande, E. ;
Glen, H. ;
Aller, J. ;
Argenziano, G. ;
Lamas, M. J. ;
Ruszniewski, P. ;
Zamorano, J. L. ;
Edmonds, K. ;
Sarker, S. ;
Staehler, M. ;
Larkin, J. .
EXPERT OPINION ON DRUG SAFETY, 2017, 16 (12) :1413-1426
[25]   Clinical use of lenvatinib in combination with everolimus for the treatment of advanced renal cell carcinoma [J].
Leonetti, Alessandro ;
Leonardi, Francesco ;
Bersanelli, Melissa ;
Buti, Sebastiano .
THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 :799-806
[26]   First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study [J].
Buti, Sebastiano ;
Bersanelli, Melissa ;
Maines, Francesca ;
Facchini, Gaetano ;
Gelsomino, Francesco ;
Zustovich, Fable ;
Santoni, Matteo ;
Verri, Elena ;
De Giorgi, Ugo ;
Masini, Cristina ;
Morelli, Franco ;
Vitale, Maria Giuseppa ;
Sava, Teodoro ;
Prati, Giuseppe ;
Librici, Carmelinda ;
Fraccon, Anna Paola ;
Fornarini, Giuseppe ;
Maruzzo, Marco ;
Leonardi, Francesco ;
Caffo, Orazio .
CLINICAL GENITOURINARY CANCER, 2017, 15 (04) :E609-E614
[27]   Adjuvant Everolimus in Non-Clear Cell Renal Cell Carcinoma A Secondary Analysis of a Randomized Clinical Trial [J].
Gulati, Shuchi ;
Tangen, Catherine ;
Ryan, Christopher W. ;
Vaishampayan, Ulka N. ;
Shuch, Brian M. ;
Barata, Pedro C. ;
Pruthi, Deepak K. ;
Bergerot, Cristiane D. ;
Tripathi, Abhishek ;
Lerner, Seth P. ;
Thompson, Ian M. ;
Lara, Primo N. ;
Pal, Sumanta K. .
JAMA NETWORK OPEN, 2024, 7 (08)
[28]   Systemic Therapy for Advanced Non-clear-Cell Renal Cell Carcinoma: Slow but Definite Progress [J].
Geynisman, Daniel M. ;
Plimack, Elizabeth R. .
EUROPEAN UROLOGY, 2021, 80 (02) :171-173
[29]   Impressive and Prolonged Response with Lenvatinib in a Highly Pretreated Patient with Metastatic Clear Cell Renal Cancer: A Case Report [J].
Demurtas, Sara ;
Frascaroli, Mara ;
Sottotetti, Federico ;
Rametta, Alessandro ;
Procopio, Giuseppe ;
Locati, Laura Deborah .
JOURNAL OF KIDNEY CANCER AND VHL, 2024, 11 (02) :1-6
[30]   A Systematic Review of Systemic Treatment Options for Advanced Non-Clear Cell Renal Cell Carcinoma [J].
Osterman, Chelsea K. ;
Rose, Tracy L. .
KIDNEY CANCER, 2020, 4 (01) :15-27
12345